Flerie
NET ASSET VALUE – 31 August 2024
MARKN.
On the 31 August 2024 Flerie AB's Net Asset Value (NAV) was SEK 4,360 million and NAV per share was SEK 55.85.
| Allocation of NAV | Share of portfolio company | Fair value (MSEK) | Part of NAV per share (SEK) | Share of NAV | |
| Product Development | |||||
| Prokarium | 42% | 473 | 6.06 | 10.9% | |
| Xspray Pharma | 18% | 303 | 3.88 | 7.0% | |
| Xintela | 56% | 205 | 2.63 | 4.7% | |
| Empros Pharma | 79% | 204 | 2.62 | 4.7% | |
| KAHR Medical | 31% | 193 | 2.47 | 4.4% | |
| Atrogi | 37% | 176 | 2.25 | 4.0% | |
| Lipum | 57% | 148 | 1.90 | 3.4% | |
| Microbiotica | 11% | 135 | 1.73 | 3.1% | |
| Mendus | 24% | 103 | 1.32 | 2.4% | |
| Geneos Therapeutics | 12% | 98 | 1.26 | 2.3% | |
| Toleranzia | 58% | 58 | 0.75 | 1.3% | |
| EpiEndo Pharmaceuticals | 9% | 56 | 0.72 | 1.3% | |
| Synerkine Pharma | 43% | 52 | 0.67 | 1.2% | |
| AnaCardio | 19% | 52 | 0.66 | 1.2% | |
| Egetis Therapeutics | 2% | 42 | 0.53 | 1.0% | |
| Buzzard Pharmaceuticals | 14% | 29 | 0.37 | 0.7% | |
| Vitara Biomedical | 5% | 27 | 0.35 | 0.6% | |
| Sixera Pharma | 23% | 26 | 0.33 | 0.6% | |
| Alder Therapeutics | 21% | 17 | 0.22 | 0.4% | |
| Amarna Therapeutics | 60% | 11 | 0.15 | 0.3% | |
| Strike Pharma | 16% | 9 | 0.11 | 0.2% | |
| Total | 2,419 | 30.98 | 55.5% | ||
| Commercial Growth | |||||
| NorthX Biologics | 92% | 189 | 2.42 | 4.3% | |
| Symcel | 31% | 169 | 2.16 | 3.9% | |
| A3P Biomedical | 8% | 75 | 0.96 | 1.7% | |
| Chromafora | 31% | 73 | 0.93 | 1.7% | |
| Provell Pharmaceuticals | 72% | 68 | 0.87 | 1.6% | |
| Nanologica | 39% | 42 | 0.54 | 1.0% | |
| Frontier Biosolutions | 2% | 19 | 0.24 | 0.4% | |
| Bohus Biotech | 45% | 17 | 0.21 | 0.4% | |
| Total | 651 | 8.34 | 14.9% | ||
| Limited Partnerships, total | 87 | 1.11 | 2.0% | ||
| Assets related to portfolio companies | 398 | 5.10 | 9.1% | ||
| Other assets and liabilities | 805 | 10.32 | 18.5% | ||
| NAV | 4 360 | 55.85 | 100.0% | ||
| * indirect shares in Provell Pharmaceuticals | |||||
| Datum | 2024-09-03, kl 08:00 |
| Källa | MFN |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet